Cargando…

The use of dual antiplatelet therapy for ischemic cerebrovascular events

In the last 10 years, the use of dual antiplatelet therapy (DAPT) in the neurological ambit has been explored in patients with non-cardioembolic ischemic stroke, transient ischemic attack (TIA), and intracranial atherosclerotic disease. Two clinical trials (CHANCE and POINT) showed that in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mele, Francesco, Gendarini, Claudia, Pantoni, Leonardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816218/ https://www.ncbi.nlm.nih.gov/pubmed/36114982 http://dx.doi.org/10.1007/s10072-022-06395-z

Ejemplares similares

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
por: De Luca, Leonardo, et al.
Publicado: (2021)

Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons
por: Hong, Keun-Sik
Publicado: (2014)

The effectiveness and safety of dual antiplatelet therapy in ischemic cerebrovascular disease with intracranial and extracranial arteriostenosis in Chinese patients: A randomized and controlled trail
por: Zuo, Feng-Tong, et al.
Publicado: (2017)

The safety of triple antiplatelet therapy under thromboelastography guidance in patients undergoing stenting for ischemic cerebrovascular disease
por: Wu, Zhonghua, et al.
Publicado: (2019)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review
por: Tsigkas, Grigorios, et al.
Publicado: (2023)

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke
por: Xian, Ying, et al.
Publicado: (2022)

Preconditioning by Preceding Ischemic Cerebrovascular Events
por: Correia, Pamela N., et al.
Publicado: (2021)

Dual Antiplatelet Therapy in Coronary Artery Disease
por: Sharma, Raghav, et al.
Publicado: (2020)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
por: Magnani, Giulia, et al.
Publicado: (2023)

Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
por: Anjum, Ibrar, et al.
Publicado: (2018)

Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning: A Single-Arm Study
por: Liu, Shimeng, et al.
Publicado: (2021)

Duration of dual antiplatelet therapy in acute coronary syndrome
por: Wilson, Simon John, et al.
Publicado: (2017)

Dual Antiplatelet Therapy: A Concise Review for Clinicians
por: Virk, Hafeez Ul Hassan, et al.
Publicado: (2023)

Ischemic and Hemorrhagic Cerebrovascular Events Related to COVID-19 Coagulopathy and Hypoxemia
por: Sojka, Michał, et al.
Publicado: (2022)

Dual Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke: A Ghost from the Past or a New Frontier?
por: Balucani, Clotilde, et al.
Publicado: (2010)

Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke
por: He, Dan, et al.
Publicado: (2022)

Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence
por: Gower, Megan N, et al.
Publicado: (2020)

Optimal duration of dual antiplatelet therapy for coronary artery disease
por: Kikkert, W. J., et al.
Publicado: (2018)

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
por: Amoda, Oluyemisi, et al.
Publicado: (2021)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis
por: Xie, Wuxiang, et al.
Publicado: (2015)

Trends in Dual Antiplatelet Therapy Use for Neurointerventional Procedures for the Management of Intracranial Aneurysms
por: Meyer, Benjamen M., et al.
Publicado: (2023)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
por: Muthspiel, Marie, et al.
Publicado: (2022)

Incorporation of Laboratory Test Biomarkers Into Dual Antiplatelet Therapy Score Improves Prediction of Ischemic and Bleeding Events in Post-percutaneous Coronary Intervention Patients
por: Sun, Chengming, et al.
Publicado: (2022)

Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging
por: Pei, Lu-lu, et al.
Publicado: (2020)

Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
por: Huseynov, Aydin, et al.
Publicado: (2019)

Dual antiplatelet therapy and drug eluting stents: a marriage of convenience
por: Benezet-Mazuecos, Juan, et al.
Publicado: (2007)

Effect of ASA on the risk of cerebrovascular ischemic events in patients with PFO
por: Xu, Liang, et al.
Publicado: (2022)

Safety and efficacy of short-term dual antiplatelet therapy combined with intensive rosuvastatin in acute ischemic stroke
por: Deng, Ting, et al.
Publicado: (2023)

Association between High Platelet Reactivity Following Dual Antiplatelet Therapy and Ischemic Events in Japanese Patients with Coronary Artery Disease Undergoing Stent Implantation
por: Nishikawa, Masakatsu, et al.
Publicado: (2020)

Effects of single versus dual antiplatelet therapy on the adverse events after transcatheter aortic valve implantation: A meta‐analysis
por: Yu, Shengqin, et al.
Publicado: (2021)

Antiplatelet combinations for prevention of atherothrombotic events
por: Bollati, Mario, et al.
Publicado: (2011)

Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls
por: Godier, Anne, et al.
Publicado: (2020)

Gastroprotection during long-term dual antiplatelet therapy: to give or not to give?
por: Sbrana, Francesco, et al.
Publicado: (2021)

Optimal dual antiplatelet therapy strategy in elderly patients with acute coronary syndrome
por: Verdoia, Monica, et al.
Publicado: (2021)

Advances in endovascular therapy for ischemic cerebrovascular diseases
por: Lu, Jun, et al.
Publicado: (2016)

Surgical tracheotomy performed with and without dual antiplatelet therapy
por: Markota, Andrej, et al.
Publicado: (2014)

Dual antiplatelet therapy and non-cardiac surgery: evolving issues and anesthetic implications
por: Song, Jong Wook, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9je5m16o8nisdgqs99qiv24flg